So Brave is Australia’s only organisation focused on supporting, educating and advocating for young women with breast cancer.
So Brave is the only breast cancer organisation in Australia dedicated to young women.
We provide information, support, and advocacy for those diagnosed 40 and under, because this experience looks different when you’re young.
At So Brave, we combine education, support, advocacy, and community action to change the experience of breast cancer for young women.
Webinars, podcasts, online resources, and workshops for schools, universities, workplaces, and health professionals.
Driving change in early detection, treatment access, and national policy so young women’s voices are heard.
National campaigns, community fundraisers, and events that raise both awareness and impact.
Explore content made for young women: podcasts, webinars, downloads, and articles.
Make a difference by hosting a morning tea, planning a workplace event, or creating your own unique fundraiser to support our mission.
Read real stories from women who’ve lived it. Because you’re not alone and you shouldn’t feel like you are.
Be #Breastaware
Be Informed. Be Educated
Be Your Own Expert
Bring So Brave into your school, university, or workplace to spark conversations, educate and empower women around their breast health.
Connect with other young women through our private support group, online events, and in-person meetups.
We believe that stories have the power to heal, to connect, and to change the way the world sees young women with breast cancer.
So Brave received the following updated revised advice from AstraZeneca this morning about the supply of Zoladex 3.6mg: The AstraZeneca
So Brave received the following updated advice from PBAC this morning: PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE (PBAC) MEETING OUTCOMES ITEMS CONSIDERED
So Brave received the following updated advice from AstraZeneca this afternoon: ONGOING ACCESS TO ZOLADEX® (goserelin) MONTHLY (3.6mg) IMPLANT IN
Amongst so many amazing things happening in our community at the moment, from incredible volunteers representing young women at the
What’s the latest on the delisting of Zoladex 3.6mg? Listen to our recent ABC News Radio interview about the situation
So Brave is aware of the cancellation notice for Zoladex Goserelin 3.6mg (as Acetate) Implant Syringe, as of November 1,
Improving diagnosis, care, and support for women diagnosed during pregnancy or postpartum The Pregnancy and Postpartum Associated Cancers (PAC) Project is being
Uniting Australia to recognise young women’s breast cancer On 1 September 2025, So Brave launched the first National Day of Awareness for
At So Brave, we encourage all women to #feelitonthefifth - not just once. Not just with their doctor. But regularly, every single month.